ArticleBritish journal of cancer2019

MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer.

Michael J G Milevskiy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.